Unlike many other weight loss medications, retatrutide targets three incretin pathways, resulting in more robust energy balance control and appetite regulation
Nitric oxide synthases in mammals
The arGLP-1 s present other differences in clinically relevant biological properties (half-life, dosing interval and molecular weight)
Extensively studied for tissue repair, GI protection, and nitric oxide system modulation
Importantly, GR signaling operates at the intersection of central stress circuits and peripheral metabolic tissues, positioning it as a compelling target for interventions aimed at long-term energy balance rather than acute appetite suppression
Recent federal programs may expand access and lower GLP-1 costs in the near future